 | • レポートコード：MRC2012B1342 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ソリリス（エクリズマブ）の世界市場を広く調査・分析し、今後の市場展望をまとめております。ソリリス（エクリズマブ）の種類別市場規模（血漿交換、血漿注入）、用途別市場規模（PNH、aHUS、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Alexion、 ・地域別グローバル市場分析 2015年-2020年 ・ソリリス（エクリズマブ）の北米市場（アメリカ、カナダ、メキシコ） ・ソリリス（エクリズマブ）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ソリリス（エクリズマブ）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ソリリス（エクリズマブ）の南米市場（ブラジル、アルゼンチン） ・ソリリス（エクリズマブ）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：血漿交換、血漿注入 ・用途別分析：PNH、aHUS、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Soliris (Eculizumab) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Soliris (Eculizumab) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Soliris (Eculizumab) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Soliris (Eculizumab) market has been segmented into:
Plasma Exchange
Plasma Infusion
By Application, Soliris (Eculizumab) has been segmented into:
PNH
aHUS
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Soliris (Eculizumab) market presented in the report. This section sheds light on the sales growth of different regional and country-level Soliris (Eculizumab) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Soliris (Eculizumab) market.
The report offers in-depth assessment of the growth and other aspects of the Soliris (Eculizumab) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Soliris (Eculizumab) Market Share Analysis
Soliris (Eculizumab) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Soliris (Eculizumab) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Soliris (Eculizumab) sales, revenue and market share for each player covered in this report.
The major players covered in Soliris (Eculizumab) are:
Alexion
Among other players domestic and global, Soliris (Eculizumab) market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Soliris (Eculizumab) Market Overview
1.1 Product Overview and Scope of Soliris (Eculizumab)
1.2 Classification of Soliris (Eculizumab) by Type
1.2.1 Global Soliris (Eculizumab) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Soliris (Eculizumab) Revenue Market Share by Type in 2019
1.2.3 Plasma Exchange
1.2.4 Plasma Infusion
1.3 Global Soliris (Eculizumab) Market by Application
1.3.1 Overview: Global Soliris (Eculizumab) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 PNH
1.3.3 aHUS
1.3.4 Other
1.4 Global Soliris (Eculizumab) Market by Regions
1.4.1 Global Soliris (Eculizumab) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Soliris (Eculizumab) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Soliris (Eculizumab) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Soliris (Eculizumab) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Soliris (Eculizumab) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Soliris (Eculizumab) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Soliris (Eculizumab) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alexion
2.1.1 Alexion Details
2.1.2 Alexion Major Business
2.1.3 Alexion SWOT Analysis
2.1.4 Alexion Product and Services
2.1.5 Alexion Soliris (Eculizumab) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Soliris (Eculizumab) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Soliris (Eculizumab) Players Market Share
3.2.2 Top 10 Soliris (Eculizumab) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Soliris (Eculizumab) Revenue and Market Share by Regions
4.2 North America Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
4.3 Europe Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
4.5 South America Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
5 North America Soliris (Eculizumab) Revenue by Countries
5.1 North America Soliris (Eculizumab) Revenue by Countries (2015-2020)
5.2 USA Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
5.3 Canada Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
5.4 Mexico Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
6 Europe Soliris (Eculizumab) Revenue by Countries
6.1 Europe Soliris (Eculizumab) Revenue by Countries (2015-2020)
6.2 Germany Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
6.3 UK Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
6.4 France Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
6.5 Russia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
6.6 Italy Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Soliris (Eculizumab) Revenue by Countries
7.1 Asia-Pacific Soliris (Eculizumab) Revenue by Countries (2015-2020)
7.2 China Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
7.3 Japan Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
7.4 Korea Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
7.5 India Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
8 South America Soliris (Eculizumab) Revenue by Countries
8.1 South America Soliris (Eculizumab) Revenue by Countries (2015-2020)
8.2 Brazil Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
8.3 Argentina Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Soliris (Eculizumab) by Countries
9.1 Middle East & Africa Soliris (Eculizumab) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
9.3 UAE Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
9.4 Egypt Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
9.5 South Africa Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Soliris (Eculizumab) Revenue and Market Share by Type (2015-2020)
10.2 Global Soliris (Eculizumab) Market Forecast by Type (2019-2024)
10.3 Plasma Exchange Revenue Growth Rate (2015-2025)
10.4 Plasma Infusion Revenue Growth Rate (2015-2025)
11 Global Soliris (Eculizumab) Market Segment by Application
11.1 Global Soliris (Eculizumab) Revenue Market Share by Application (2015-2020)
11.2 Soliris (Eculizumab) Market Forecast by Application (2019-2024)
11.3 PNH Revenue Growth (2015-2020)
11.4 aHUS Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Soliris (Eculizumab) Market Size Forecast (2021-2025)
12.1 Global Soliris (Eculizumab) Market Size Forecast (2021-2025)
12.2 Global Soliris (Eculizumab) Market Forecast by Regions (2021-2025)
12.3 North America Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
12.4 Europe Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
12.6 South America Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Soliris (Eculizumab) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Soliris (Eculizumab) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Soliris (Eculizumab) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Soliris (Eculizumab) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Soliris (Eculizumab) Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Alexion Corporate Information, Location and Competitors
Table 7. Alexion Soliris (Eculizumab) Major Business
Table 8. Alexion Soliris (Eculizumab) Total Revenue (USD Million) (2017-2018)
Table 9. Alexion SWOT Analysis
Table 10. Alexion Soliris (Eculizumab) Product and Solutions
Table 11. Alexion Soliris (Eculizumab) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Global Soliris (Eculizumab) Revenue (Million USD) by Players (2015-2020)
Table 13. Global Soliris (Eculizumab) Revenue Share by Players (2015-2020)
Table 14. Global Soliris (Eculizumab) Revenue (Million USD) by Regions (2015-2020)
Table 15. Global Soliris (Eculizumab) Revenue Market Share by Regions (2015-2020)
Table 16. North America Soliris (Eculizumab) Revenue by Countries (2015-2020)
Table 17. North America Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Table 18. Europe Soliris (Eculizumab) Revenue (Million USD) by Countries (2015-2020)
Table 19. Asia-Pacific Soliris (Eculizumab) Revenue (Million USD) by Countries (2015-2020)
Table 20. South America Soliris (Eculizumab) Revenue by Countries (2015-2020)
Table 21. South America Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Table 22. Middle East and Africa Soliris (Eculizumab) Revenue (Million USD) by Countries (2015-2020)
Table 23. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Table 24. Global Soliris (Eculizumab) Revenue (Million USD) by Type (2015-2020)
Table 25. Global Soliris (Eculizumab) Revenue Share by Type (2015-2020)
Table 26. Global Soliris (Eculizumab) Revenue Forecast by Type (2021-2025)
Table 27. Global Soliris (Eculizumab) Revenue by Application (2015-2020)
Table 28. Global Soliris (Eculizumab) Revenue Share by Application (2015-2020)
Table 29. Global Soliris (Eculizumab) Revenue Forecast by Application (2021-2025)
Table 30. Global Soliris (Eculizumab) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Soliris (Eculizumab) Picture
Figure 2. Global Soliris (Eculizumab) Revenue Market Share by Type in 2019
Figure 3. Plasma Exchange Picture
Figure 4. Plasma Infusion Picture
Figure 5. Soliris (Eculizumab) Revenue Market Share by Application in 2019
Figure 6. PNH Picture
Figure 7. aHUS Picture
Figure 8. Other Picture
Figure 9. Global Soliris (Eculizumab) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Soliris (Eculizumab) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Soliris (Eculizumab) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Soliris (Eculizumab) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Soliris (Eculizumab) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Soliris (Eculizumab) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Soliris (Eculizumab) Revenue Market Share by Regions in 2018
Figure 23. North America Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 26. South America Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 28. North America Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Soliris (Eculizumab) Revenue Market Share by Countries in 2019
Figure 30. USA Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Soliris (Eculizumab) Revenue Market Share by Countries in 2019
Figure 35. Germany Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 36. UK Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 37. France Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Countries in 2019
Figure 42. China Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 45. India Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 47. South America Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Soliris (Eculizumab) Revenue Market Share by Countries in 2019
Figure 49. Brazil Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Soliris (Eculizumab) Revenue and Growth Rate (2015-2020)
Figure 57. Global Soliris (Eculizumab) Revenue Share by Type (2015-2020)
Figure 58. Global Soliris (Eculizumab) Revenue Share by Type in 2019
Figure 59. Global Soliris (Eculizumab) Market Share Forecast by Type (2021-2025)
Figure 60. Global Plasma Exchange Revenue Growth Rate (2015-2020)
Figure 61. Global Plasma Infusion Revenue Growth Rate (2015-2020)
Figure 62. Global Soliris (Eculizumab) Revenue Share by Application (2015-2020)
Figure 63. Global Soliris (Eculizumab) Revenue Share by Application in 2019
Figure 64. Global Soliris (Eculizumab) Market Share Forecast by Application (2021-2025)
Figure 65. Global PNH Revenue Growth Rate (2015-2020)
Figure 66. Global aHUS Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Soliris (Eculizumab) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Soliris (Eculizumab) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Soliris (Eculizumab) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
Figure 72. Europe Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
Figure 74. South America Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Soliris (Eculizumab) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ソリリス薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Soliris Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Soliris Drug market report provi…- 治療用血漿交換の世界市場（～2026年） Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…
- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- プラズマアーク切断の世界市場（～2026年） Market Analysis and Insights: Global Plasma Arc Cutting Market The global Plasma Arc Cutting market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 血漿分画の世界市場（～2026年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…